Immunic reported $-23.33M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
BioMarin Pharmaceutical USD 205.6M 100M Sep/2026
Cipla INR 10.43B 1.55B Sep/2026
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -8.84M 180K Jun/2026
CSL USD 2.64B 1.97B Dec/2025
Enanta Pharmaceuticals USD -23.54M 98.15M Dec/2024
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
Insmed USD -81.83M 19.48M Sep/2026
Omeros USD -35.41M 23.75M Sep/2024
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD 12.1M 27.4M Sep/2026
Ultragenyx Pharmaceutical USD -110M 35M Sep/2026
United Therapeutics USD 241.3M 89.5M Sep/2026